ClinicalTrials.gov record
Recruiting Phase 4 Interventional

Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer

ClinicalTrials.gov ID: NCT05803941

Public ClinicalTrials.gov record NCT05803941. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 2:00 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase IV, Post-Authorization Safety Study to Investigate the Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Adult Participants With Prostate Cancer

Study identification

NCT ID
NCT05803941
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 4
Lead sponsor
Novartis Pharmaceuticals
Industry
Enrollment
700 participants

Conditions and interventions

Interventions

  • AAA617 Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 100 Years
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 13, 2023
Primary completion
Jul 19, 2033
Completion
Jul 20, 2033
Last update posted
Apr 23, 2025

2023 – 2033

United States locations

U.S. sites
24
U.S. states
20
U.S. cities
22
Facility City State ZIP Site status
Mayo Clinic Arizona Scottsdale Arizona 85259 Recruiting
St. Joseph Hospital Orange California 92686 Recruiting
Providence Saint Johns Health Ctr Santa Monica California 90404 Recruiting
University of Colorado Aurora Colorado 80045 Recruiting
Hartford Hospital Hartford Connecticut 06102 Recruiting
VA Medical Center Washington D.C. District of Columbia 20422 Recruiting
Mayo Clinic Jacksonville Jacksonville Florida 32224 Recruiting
University Cancer and Blood Center LLC Athens Georgia 30607 Recruiting
Parkview Research Center Fort Wayne Indiana 46845 Recruiting
Tulane Cancer Center New Orleans Louisiana 70112 Recruiting
Ochsner Clinic Foundation New Orleans Louisiana 70121 Recruiting
Corewell Health William Beaum Hosp Royal Oak Michigan 48073-6769 Recruiting
Mayo Clinic Rochester Rochester Minnesota 55905 Recruiting
University of Mississippi Med Ctr Jackson Mississippi 39216 Recruiting
Wash U School of Medicine St Louis Missouri 63110 Recruiting
Urology Cancer Center PC Omaha Nebraska 68130 Recruiting
Nebraska Cancer Specialists Omaha Nebraska 68154 Recruiting
Montefiore Medical Center The Bronx New York 10467 Recruiting
Duke University Medical Center Durham North Carolina 27710 Recruiting
Cleveland Clinic Foundation Cleveland Ohio 44195 Recruiting
Univ of Pittsburgh Medical Center Pittsburgh Pennsylvania 15232 Recruiting
Univ of Texas Southwest Med Center Dallas Texas 75390-9034 Recruiting
UT Health Science Center Houston Texas 77030 Recruiting
Onco Hemato Asso of SE Virginia Roanoke Virginia 24014 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 30 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05803941, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 23, 2025 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05803941 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →